Treatment gains observed at 6-month follow-up ( 6MFU ) on measures of clinical severity , general symptoms of depression and anxiety , and a measure of symptom interference in daily functioning were largely maintained 12months later ( at an average of 18months posttreatment ) , and any significant changes from 6MFU to LTFU reflected small increases in symptoms that remained , on average , in the subclinical range .